ENTERPRISE THERAPEUTICS LTD

Sussex Innovation Centre, Brighton, United Kingdom

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

50.0%

Trial Status Distribution

Active, not recruiting

25.0%

Completed

75.0%

Clinical Trials

Trials sponsored by this organization (4)

A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis

Phase 2

Completed

interventional

Jun 202457 participants

A two-part study to assess the effectiveness, safety, and blood levels of repeat doses of inhaled ETD001 in people with cystic fibrosis

Phase 2

Active, not recruiting

interventional

Apr 202435 participants

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

Phase 1

Completed

interventional

Jun 202198 participants

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects

Phase 1

Completed

interventional

Aug 202080 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations